Former executives of Irish drugmaker Elan Corp. have launched Fountain Healthcare Partners, a venture capital fund valued at more than $116 million, to help startup companies in four fields: biotechnology, specialty pharmaceuticals, diagnostics and medical devices. The Dublin-based fund, whose investors include the European Investment Fund, has established an office in New York to keep track of developments in the U.S. life sciences sector.

Related Summaries